Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-97.76	65.90	2947.95
Graham Fair Price	41.43	1.42	1.01
PEG	-72.82	0.17	-0.62
Price/Book	-1.17	0.48	0.48
Price/Cash Flow	-50.59	118.07	238.93
Prices/Earnings	-50.59	16.86	34.12
Price/Sales	-50.59	29.54	59.78
Price/FCF	-50.59	118.07	238.93
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-55.04	0.26	0.57
Operating Margin	-31.15	0.09	-0.13
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	40.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.02	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.43	2.38	66.59
EPS QOQ	-0.55	1.00	81.82
FCF QOQ	-0.72	1.00	39.81
Revenue QOQ	-0.52	1.00	93.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.43	0.12	-71.25
Days Sales Outstanding (DSO)	7.82	61.42	685.28
Inventory Turnover	208.96	726.92	247.87
Debt/Capitalization	< 0.005	< 0.005	0.00
Quick Ratio	42.21	43.65	3.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.57	3.57	< 0.005
Cash	1.08	1.08	< 0.005
Capex	< 0.005	< 0.005	-100.02
Free Cash Flow	< 0.005	0.01	100.02
Revenue	0.03	0.06	100.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	43.65	43.65	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-102.53	-7.41	92.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating